Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Go back to Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis| Medtronic Inc. (NYSE: MDT) | Delayed: 92.33 -0.06 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.39 | 52 Week High | $89.27 | |||
| Open | $92.39 | 52 Week Low | $71.03 | |||
| Day High | $93.39 | P/E | 26.23 | |||
| Day Low | $91.75 | EPS | $3.52 | |||
| Volume | 2,408,635 | |||||
